title: What can breast cancer molecular sub-classification add to conventional diagnostic tools?
authors.affiliation: Breast cancer Unit and Translational Research Unit, Institut Gustave Roussy, Villejuif.
authors.forename: F
authors.initials: F
authors.lastname: André
authors.forename: J
authors.initials: J
authors.lastname: Domont
authors.forename: S
authors.initials: S
authors.lastname: Delaloge
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D001943:Breast Neoplasms / Q000145:classification* / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D003952:Diagnostic Imaging; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008967:Molecular Biology / Q000145:classification*; D011379:Prognosis; D012680:Sensitivity and Specificity
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor